Biocon Biologics in talks with ADQ to raise fresh capital
Kiran Mazumdar-led Biocon Biologics is in the midst of a fund raising blitzkrieg in 2020. It recently sealed a deal with Wall Street powerhouse Goldman Sachs and now it’s in talks for a fourth fund raise.
Kiran Mazumdar-led Biocon Biologics is in the midst of a fund raising blitzkrieg in 2020. It recently sealed a deal with Wall Street powerhouse Goldman Sachs and now it’s in talks for a fourth fund raise.
According to a report by moneycontrol.com, post the Goldman Sachs deal, Biocon Biologics is now in talks with ADQ for a fresh shot of funds.
ADQ is a sovereign wealth fund owned by Abu Dhabi government. ADQ is looking to invest up to 100 million dollars in Biocon Biologics and due diligence is underway.
Watch this video for more.
(Edited by : Abhishek Jha)
First Published: Nov 24, 2020 2:59 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Odisha's new CM — who is Mohan Charan Majhi and what prompted the BJP to choose him
Jun 13, 2024 2:54 PM
Election 2024: 504 out of 543 newly-elected MPs are ‘crorepatis’ – Check 10 richest members in 18th Lok Sabha
Jun 12, 2024 9:55 PM
BJP to start nationwide organisational rejig, new party president to be elected soon
Jun 12, 2024 9:31 AM
New Lok Sabha Speaker to be elected in special 8-day session: Report
Jun 11, 2024 6:28 PM